Dr. Daniel Joseph Mark, MD

Dr. Mark practices at Genesiscare Usa of Florida in Cape Coral, Florida.

Dr. Mark's NPI, 1902291412, was assigned on April 1, 2015. Dr. Mark graduated from Albert Einstein College of Medicine in 2015. Dr. Mark holds Florida license ME145185.

Dr. Mark's primary practice is Genesiscare Usa of Florida, at 1419 SE 8th Ter, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 489-3420.

Dr. Mark's primary practice is Genesiscare Usa of Florida in Cape Coral, Florida. Dr. Mark is also affiliated with Northern Westchester Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Mark to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mark practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mark's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mark is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Mark's licenses on file in 2 states: Florida and New York.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Mark treats.

CMS data shows 8,006 Medicare services from Dr. Mark across 21 procedure codes in 2024, for 202 Medicare patients. Medicare paid $1,434,710 for them. Every service was in an office.

CMS counts 202 Medicare patients who saw Dr. Mark in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mark's median patient age at 74, with 42% women.

In 2024, Dr. Mark wrote 73 Medicare Part D claims for 42 patients. 82% of them were for generic drugs. CMS names the drug for 41 of them, across 2 drugs with 11 or more claims each, at $711 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Dr. Mark accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Mark, published from 2015 to 2019. Dr. Mark's most frequent co-authors are Daniel B. Mark, MD, Jana Lauren Fox, MD and Madhur K. Garg, MD.

CMS Open Payments shows 127 general payments to Dr. Mark from 31 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 83% of the total. Carl Zeiss Meditec USA, Inc. paid the most, $1,186.

Dmand AI lists 1 award for Dr. Mark, most recently Best of ASTRO Abstract in 2018.

Dr. Mark graduated from Albert Einstein College of Medicine in 2015.

Dr. Mark is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.